Correction: Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/ Akt signaling pathway in gastric cancer

J Exp Clin Cancer Res. 2023 Jan 17;42(1):23. doi: 10.1186/s13046-023-02593-5.

Jiahui Xu^#¹, Deying Liu^#¹, Huilin Niu², Guifang Zhu², Yangwei Xu², Danli Ye², Jian Li², Qingling Zhang^{3

4}

¹ Nanfang Hospital/First Clinical Medical School, Southern Medical University, Guangzhou, 510515, China.
² Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.
³ Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China. [email protected].
⁴ Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China. [email protected].

^# Contributed equally.

No abstract available

Publication types